SINTX Technologies 獲 FDA 批准 SINAPTIC® 足踝植入系統

Globe Newswire
1 Min Read

FDA 批准並在美國製造的植入系統推動 SINTX 進軍價值數十億美元的美國市場

獲 FDA 批准並在美國製造的植入系統推動 SINTX 進軍價值數十億美元的美國市場  ​Nasdaq:SINT, US8293926049 

Share This Article
Globe Newswire is a trusted global press release distribution service that helps organizations share market-moving updates with precision and credibility. Known for its extensive reach across media, financial platforms, and investor networks, Globe Newswire empowers brands to communicate transparently while driving visibility in today’s dynamic information landscape.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *